Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products NewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals


Merck Proxy Statement
Election of Directors
2003
Questions and Answers About the Annual Meeting and Voting
Questions and Answers About the Annual Meeting and Voting
Election of Directors
Security Ownership and Compensation
Performance Graph
Audit Committee
Ratification of Appointment of Independent Public Accountants
Adoption of the 2003 Incentive Stock Plan
Stockholder Proposals
Other Matters
Appendices
Proxy Home

1. Election of Directors

Five directors are to be elected by stockholders at the Annual Meeting for three-year terms expiring in 2006. The Board's nominees are Mr. Lawrence A. Bossidy, Dr. Johnnetta B. Cole, Mr. William B. Harrison, Jr., Dr. William N. Kelley and Dr. Heidi G. Miller. All candidates have previously been elected by stockholders. Mr. Niall FitzGerald and Dr. Edward M. Scolnick resigned from the Board effective October 18, 2002 and December 31, 2002, respectively. After the election of five directors at the Annual Meeting, the Company will have eleven directors, including the six continuing directors whose present terms extend beyond the meeting. Information on the nominees and continuing directors follows.

Nominees
Directors Whose Terms Expire in 2004
Directors Whose Terms Expire in 2005
Board Committees
Board and Board Committee Meetings
Compensation Committee Interlocks and Insider Participation
Independence of Directors
Relationships with Outside Firms
Board's Role in Strategic Planning
Compensation of Directors


Contact Merck Site MapAccessibility StatementPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.